BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190219
DTEND;VALUE=DATE:20190221
DTSTAMP:20260514T232819
CREATED:20180926T073514Z
LAST-MODIFIED:20180926T073514Z
UID:17758-1550534400-1550707199@www.pharmajournalist.com
SUMMARY:Pharma Security Asia 2019
DESCRIPTION:The importance of the pharmaceutical industry in the modern-day Asian society cannot be overstressed especially as there are new diseases springing up from different areas\, strengthening the importance of adequate drug research and development activities. However\, with the growth of the industry in Asia comes the increase in fake drugs. In recent times\, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO)\, about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate\, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales.\nWe require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters.\nThus\, To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security Asia 2019 – An Anti-Counterfeiting\, Drug Serialization and Supply-Chain Security Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. \nSocial Media: \n@corvusglobal\nhttps://www.facebook.com/corvusglobalevents/\nhttps://twitter.com/corvusglobal?lang=en
URL:https://www.pharmajournalist.com/event/pharma-security-asia-2019/
LOCATION:Singapore\, Singapore
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190219
DTEND;VALUE=DATE:20190222
DTSTAMP:20260514T232819
CREATED:20181123T082750Z
LAST-MODIFIED:20181123T082750Z
UID:18485-1550534400-1550793599@www.pharmajournalist.com
SUMMARY:7th World CNS Summit
DESCRIPTION:The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research. \n \nWorld CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees\, helping to overcome the translational challenges in developing efficacious therapeutics. \nDeveloped in combination with experts from Biogen\, Eisai\, Merck\, AbbVie and other leading organizations\, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting. \nFollowing numerous neurodegenerative disease clinical failures\, the neurodegenerative disease field requires a refreshed approach towards drug development to drive clinical success. \nNow in its 7th successful year\, the World CNS Summit challenges traditional thinking to guide drug development of efficacious treatments for neurodegeneration\, bringing together over 150+ leading minds in the neurodegenerative space\, from academia\, pharma\, biotech and leading consortia\, to provide a unique opportunity to bridge the gap of translational drug development. \nTo learn more and to register online\, visit http://bit.ly/2AfTc9J
URL:https://www.pharmajournalist.com/event/7th-world-cns-summit/
LOCATION:Seaport Hotel & World Trade Center\, One Seaport Lane\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190220
DTEND;VALUE=DATE:20190222
DTSTAMP:20260514T232819
CREATED:20181025T121157Z
LAST-MODIFIED:20181025T121157Z
UID:18118-1550620800-1550793599@www.pharmajournalist.com
SUMMARY:3rd Annual 3D Cell Culture
DESCRIPTION:SMi’s 3rd Annual 3D Cell Culture\nDelivering updates on the development and application of human organs and tissues in vitro\n \nProudly sponsored by InoCure & TEDD Competence Centre \nCHAIRED BY: \nNicola Valeri\, Gastrointestinal Cancer Biology and Genomics Team Leader\, The Institute of Cancer Research\nStefan Przyborski\, Professor of Cell Technology\, University of Durham \nCell Culture in an important tool for research and development within the life science industry. Over the past few years\, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods. 3D cell culture enables cells to grow and interact with their surroundings in all three dimensions\, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring\, cell viability\, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans. \n \nResearchers globally are realizing the potential of 3D cell culture for various applications\, including testing and discovering new drugs to treat cancer\, organ-on-chip models to study the human physiology in an organ specific context\, and 3D cell printing to produce organ models. Therefore\, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022\, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting\, funding from governments and private entities and technological advancements in the field. \nAt the 3D Cell Culture Conference in February\, we will look at the latest developments in the 3D Cell Culture field. Participants will have the opportunity to network with industry experts\, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development\, discuss the potential for novel in-vitro cell culture models to replace animal models\, and discover novel 3D cell culture systems\, organ-on-chip\, 3D imaging of organoids and other technologies in development. \nEvent Hashtag: #SMi3DCellCulture \nFEATURED SPEAKERS INCLUDE: \nGUEST SPEAKER: \n\nBill Mattes\, Director\, Division of Systems Biology\, FDA \n\nSPEAKERS INCLUDE: \n\nAsli Akidil\, Cell and Molecular Scientist\, AstraZeneca\nGary Allenby\, Business Development Director and Chief Scientific Officer\, Aurelia Biosciences\nJason Ekert\, Head of Complex In Vitro Models\, GSK\nPhilip Hewitt\, UK and Eurotox Registered Toxicologist\, Head of Early Investigative Technology\, Merck\nStefan Kustermann\, Lab Head\, Investigative Safety\, Roche\nVeronique Barban\, Expert Virology\, Research and Nonclinical Safety Department\, Sanofi Pasteur\n\nKEY TOPICS FOR 2018 INCLUDE: \n\nOrgan-on-chip technologies and their applications in the pharmaceutical industry\nPanel discussion on whether 3D Cell Culture will replace animal models\nDetermining the predictive validity of 3D models and achieving standardization for preclinical testing\nGlobal developments in 3D Cell Culture and how this exponential growth will impact researchers\nSeveral novel techniques for imaging of 3D Cell Cultures\nDevelopment of 3D eye models for early assessment of retinal toxicity\nMusculoskeletal regeneration harnessing preclinical models for tissue repair\n\nView the full agenda: http://www.3d-cellculture.com/pjwl \nWHO SHOULD ATTEND \nBiotech / Pharma Companies – Team Leader\, Junior Principle investigator\, Cell and Molecular Scientist\, Chief Scientific Officer\, Deputy Director\, Manager\, Founder\, CEO\, Head\, Director\, Programme Manager\, Lab Head\, Toxicologist \nAcademia Professor – Cell Technology\, Stem Cell Sciences\, Biochemistry\, Protein Technology and Tissue Engineering \nSolution Providers – Manager\, Head of\, CEO\, Director\, Founder\, Account Manager\, President\, CSO\, Executive\, Managing Director\, Vice President\, COO \nOrganisations / Regulatory – Director\, Senior Science Advisor\, Scientific Officer  \nEARLY BIRD-RATES \n\nBOOK BY 31ST OCTOBER AND SAVE £400\nBOOK BY 30TH NOVEMBER AND SAVE £200\nBOOK BY 14TH DECEMBER AND SAVE £100
URL:https://www.pharmajournalist.com/event/3rd-annual-3d-cell-culture/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd.":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190220
DTEND;VALUE=DATE:20190222
DTSTAMP:20260514T232819
CREATED:20181119T145121Z
LAST-MODIFIED:20181119T145121Z
UID:18459-1550620800-1550793599@www.pharmajournalist.com
SUMMARY:Pharma Packaging and Labeling East Coast 2019
DESCRIPTION:Now in its 11th year\, Pharma Packaging and Labeling is back to deliver key\, actionable insights into very latest regulatory requirements\, technological innovations\, strategic developments\, and how to implement them into your packaging and labeling chain with both maximum efficiency and minimal cost. \n \nWith evolving regulations and tougher anti-counterfeiting rules\, ensuring patient safety and the right systems are in place is more crucial than ever. Meeting the deadlines and adhering to regulations will not only ensure compliance but will also deliver huge benefits to your business and the industry \nWith popular demand\, the US Drug Enforcement Agency will be back to answer questions on current anti-counterfeit regulations and how this will impact your business. The 2019 speaker line up brings together regulatory bodies and pharma companies including the DSCSA\, US Customs & Borders\, Pfizer\, Merck\, Trevena\, Biogen\, Alkermes and an insight into CMOs including PharmoRx Therapeutics\, among many others. \nPharma Packaging and Labeling will bring you everything you need to ensure a successful and compliant implementation for your packaging and labeling. With a more interactive and hands on agenda including panel discussions; roundtables; speed networking; think tanks; mini workshops and more\, this event will create an environment where commercial packaging and labeling teams from across all sizes of manufacturer can work together to manage creative\, technical\, and regulatory demands while ensuring patients are safeguarded at all stages. \nFor more details\, please visit http://www.arena-international.com/pharmapackagingeast/
URL:https://www.pharmajournalist.com/event/pharma-packaging-and-labeling-east-coast-2019/
LOCATION:Philadelphia\, Pennsylvania
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
END:VCALENDAR